Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases

被引:17
|
作者
Kamata, M
Denda-Nagai, K
Kubota, N
Aida, S
Takeda, K
Irimura, T
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan
[2] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan
关键词
DNA vaccine; natural killer cells; tumor immunity;
D O I
10.1023/A:1021332932531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
C57BL/6 mice were immunized intradermally with various doses of purified pCEP4 plasmid DNA containing full-length MUC1 cDNA (22 tandem repeats). Mice immunized with MUC1 DNA three times at weekly intervals had serum antibodies to a synthetic peptide corresponding to the tandem repeats of MUC1. The antibody titer correlated with the plasmid DNA dose. After the third immunization mice were injected intravenously with 5 x 10(5) B16-F10 melanoma cells that had been stably transfected with MUC1 cDNA (F10-MUC1-C8 clone cells). The number of lung metastatic nodules three weeks after inoculation of F10-MUC1-C8 cells was significantly lower in mice immunized with MUC1 plasmid DNA than in mice immunized with the vector DNA alone. Thus, the suppression of lung metastasis was antigen-specific. In vivo depletion of lymphocyte subpopulations by specific antibodies revealed that natural killer cells are the major effector cells responsible for the suppression of lung metastasis. CD4(+) cells and CD8(+) cells apparently played some roles too.
引用
收藏
页码:689 / 696
页数:8
相关论文
共 50 条
  • [41] VACCINIA VIRUS MUC1 IMMUNIZATION OF MICE - IMMUNE-RESPONSE AND PROTECTION AGAINST THE GROWTH OF MURINE TUMORS BEARING THE MUC1 ANTIGEN
    ACRES, RB
    HAREUVENI, M
    BALLOUL, JM
    KIENY, MP
    JOURNAL OF IMMUNOTHERAPY, 1993, 14 (02) : 136 - 143
  • [42] Amplification of MUC1 in prostate cancer metastasis and CRPC development
    Wong, Nicholas
    Major, Pierre
    Kapoor, Anil
    Wei, Fengxiang
    Yan, Judy
    Aziz, Tariq
    Zheng, Mingxing
    Jayasekera, Dulitha
    Cutz, Jean-Claude
    Chow, Mathilda Jing
    Tang, Damu
    ONCOTARGET, 2016, 7 (50) : 83115 - 83133
  • [43] MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma
    Lappi-Blanco, Elisa
    Makinen, Johanna
    Laitakari, Kirsi
    Johnson, Shirley
    Makitaro, Riitta
    Bloigu, Risto
    Lehtonen, Siri
    Vaisanen, Timo
    Kaarteenaho, Riitta
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [44] Human tumor antigen MUC1-based vaccines in human MUC1 and HLA transgenic mice
    Soares, MM
    Finn, OJ
    FASEB JOURNAL, 1999, 13 (04): : A304 - A304
  • [45] Hypoxia enhances MUC1 expression in a lung adenocarcinoma cell line
    Mikami, Yuji
    Hisatsune, Akinori
    Tashiro, Tomomi
    Isohama, Yoichiro
    Katsuki, Hiroshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (04) : 1060 - 1065
  • [46] Development of Tn Antigen Derivative Vaccines Targeting MUC1
    Hachisu, Masakazu
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 2019, 31 (180) : E89 - E90
  • [47] MUC1 expression is increased during human placental development and suppresses trophoblast-like cell invasion in vitro
    Shyu, Ming-Kwang
    Lin, Mei-Chun
    Liu, Chiung-Hui
    Fu, Yen-Rong
    Shih, Jin-Chung
    Lee, Chien-Nan
    Chen, Hsiao-Yu
    Huang, John
    Huang, Min-Chuan
    Hsieh, Fon-Jou
    BIOLOGY OF REPRODUCTION, 2008, 79 (02) : 233 - 239
  • [48] Protection against MUC1 expressing mouse tumours by intra-muscular injection of MUC1 cDNA requires functional CD8+ and CD4+ T cells but does not require the MUC1 tandem repeat domain
    Plunkett, T
    Graham, R
    Correa, I
    Sewell, R
    Miles, D
    Burchell, J
    Taylor-Paradimitriou, J
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (05) : 691 - 697
  • [49] Vaccination against the polymorphic epithelial mucine MUC1 commonly overexpressed in breast cancer
    Scholl, SM
    Pouillart, P
    BULLETIN DU CANCER, 1997, 84 (01) : 61 - 64